Gain Therapeutics Inc (NAS:GANX)
$ 2.08 -0.09 (-4.15%) Market Cap: 53.11 Mil Enterprise Value: 39.16 Mil PE Ratio: 0 PB Ratio: 4.43 GF Score: 67/100

Gain Therapeutics Inc at Sidoti & Company January Micro-Cap Virtual Conference Transcript

Jan 18, 2023 / 07:30PM GMT
Release Date Price: $3.71 (-1.33%)
Unidentified Participant

Hello, everyone, and welcome to the Sidoti conference in January. We have a pleasure today of having Gain Therapeutics with us. Matthias Alder, the CEO, will be presenting. And this is an interesting company; it has therapy which actually deals with protein misfolding disorders. Many of you may look -- think about what that means. And Matthias is going to give a very good explanation of those diseases and how his technology can potentially be very helpful.

So Matthias, let me turn it over to you.

Matthias Alder
Gain Therapeutics, Inc. - CEO

Thank you, Howard. And thanks, everybody, for joining. It's a pleasure to have you here. I think it's a great conference, so kudos to Sidoti, and to Howard and team for setting this up. And I look forward to presenting to give you some update on what we're up to at Gain, the exciting lead program, our platform, and the highlights that are going to come up this year at Gain Therapeutics.

We're a publicly traded company. So as you're thinking about making investments, please look at our SEC

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot